Inventor · disambiguated record
Larry Schlesinger
Also filed as: SCHLESINGER LARRY · SCHLESINGER LARRY S
12 granted patents·8 pending applications·131 citations·filing 1996–2024
89Inventor score
Files withOHIO STATE INNOVATION FOUNDATION3TEXAS BIOMEDICAL RES INSTITUTE3CHEN CHING-SHIH2RIGNEY BRIAN P2SCHLESINGER LARRY2
Top patents by PatentIndex Score
20 records- 0193US8039502B2Anti-infective agents against intracellular pathogensUNIV OHIO STATE RES FOUND·Filed 2008·Granted Oct 18, 2011·16 cites·15 claims
- 0286US8576059B2Tire monitoring systems and methodsRIGNEY BRIAN P·Filed 2011·Granted Nov 5, 2013·7 cites·27 claims
- 0385US8905060B2Tamper-resistant caps, assemblies and systems for use with a valveSCHLESINGER LARRY·Filed 2012·Granted Dec 9, 2014·10 cites·29 claims
- 0481US6203822B1Gallium-containing compounds for the treatment of infections caused by intracellular pathogens and pathogens causing chronic pulmonary infectionUNIV IOWA RES FOUND·Filed 1996·Granted Mar 20, 2001·59 cites·18 claims
- 0575US8516882B2Tire pressure monitoring apparatuses, systems and methodsRIGNEY BRIAN P·Filed 2011·Granted Aug 27, 2013·2 cites·21 claims
- 0673US8445483B1Anti-infective agents against intracellular pathogensCHEN CHING-SHIH·Filed 2011·Granted May 21, 2013·1 cites·16 claims
- 0772US5997912AMethod for inhibiting growth of P. aeruginosa using gallium-containing compoundsUNIV IOWA RES FOUND·Filed 1997·Granted Dec 7, 1999·36 cites·16 claims
- 0868US2025051730A1Cell culture media and methods for generating human alveolar macrophage-like cellsTEXAS BIOMEDICAL RES INSTITUTE·Filed 2024·Application pending·0 cites
- 0963US12173326B2Cell culture media and methods for generating human alveolar macrophage-like cellsTEXAS BIOMEDICAL RES INSTITUTE·Filed 2022·Granted Dec 24, 2024·0 cites·9 claims
- 1062US2011124681A1Topical and injectable formulations comprising leukotriene receptor antagonist and uses thereofSCHLESINGER LARRY S·Filed 2009·Application pending·0 cites
- 1159US2022016272A1Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disordersCARDINAL HEALTH 414 LLC·Filed 2021·Application pending·0 cites
- 1255US10028933B2Compositions and methods for inhibiting the growth of multi-drug resistant microbesOHIO STATE INNOVATION FOUNDATION·Filed 2016·Granted Jul 24, 2018·0 cites·14 claims
- 1354US2024180929A1Treatment of infectious diseases using bcl-2 family protein inhibitorsTEXAS BIOMEDICAL RES INSTITUTE·Filed 2021·Application pending·0 cites
- 1452US8580827B2Anti-Francisella agentsCHEN CHING-SHIH·Filed 2012·Granted Nov 12, 2013·0 cites·6 claims
- 1552US2015023876A1Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disordersNAVIDEA BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1648US2022211680A1Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using sameOHIO STATE INNOVATION FOUNDATION·Filed 2020·Application pending·0 cites
- 1746US9457031B2Antibacterial protein kinase inhibitorsUNIV OHIO STATE·Filed 2013·Granted Oct 4, 2016·0 cites·2 claims
- 1843US10806803B2Compositions for targeting macrophages and other CD206 high expressing cells and methods of treating and diagnosisOHIO STATE INNOVATION FOUNDATION·Filed 2015·Granted Oct 20, 2020·0 cites·11 claims
- 1930US2017202969A1Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using sameSCHLESINGER LARRY·Filed 2015·Application pending·0 cites
- 2025US2016213647A1Compositions and methods for inhibiting viral infectionARNO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →